Can you buy stock in Medline?

You can buy Medline shares through your preferred brokerage account, like you would any other public company.

Is Medline publicly traded?

Medline is publicly traded under the ticker symbol MDLN.

Is Medline going public?

Medline held its IPO on Dec. 17, 2025.

Is Medline a good stock to buy?

Medline could be a smart buy-and-hold opportunity for long-term investors seeking a durable, recession-resilient business. Medline’s value proposition lies in its immense physical footprint, structural competitive advantages, and essential role in the everyday operations of the global healthcare system.

What is the future price of Medline stock?

For long-term investors, immediate price fluctuations matter less than structural valuation growth. That said, Medline stock is widely considered undervalued given its defensive qualities and long-term earnings prospects. Wall Street analysts have released 12-month price targets ranging from $53 at the median to $62 at the high end, representing potential upside of 46% to 71%.

How to Buy Medline Stock (MDLN) in 2026

By Rachel Warren – Updated May 20, 2026 at 12:33 AM EST | Fact-checked by Frank Bass

Key Points

Medline's IPO raised $6.26 billion, largest in 2025, under ticker MDLN.
Medline manufactures 335,000+ products globally, ensuring supply chain control.
2025 net sales at Medline grew 11.5%, reaching $28.4 billion.

Medline Inc. (MDLN +1.46%) is the largest manufacturer and distributor of medical supplies in the United States and provides a wide range of solutions to healthcare providers across all care settings. The company was founded in 1966 by Jim and Jon Mills and has a long history in medical garment manufacturing and supply distribution. Operating in more than 100 countries, Medline manufactures and distributes over 335,000 medical and surgical products worldwide.

Loading paragraph...

Back room in hospital containing shelves filled with medical supplies. — Image source: Getty Images.

Loading image...

Its global portfolio spans wound care and first-aid supplies, medical devices, and home healthcare products for hospitals, clinics, and patients. The company also provides supply chain solutions, analytics, and educational resources to support healthcare providers. Medline completed its initial public offering (IPO) in December 2025 and is listed on the Nasdaq stock exchange under the ticker symbol MDLN.

In the largest IPO of the year, the company raised approximately $6.26 billion in its market debut. Prior to the IPO, a private equity consortium that included Blackstone (BX +1.43%), Carlyle (CG +0.08%), and Hellman & Friedman, held a majority stake via a 2021 $34 billion leveraged buyout. The firms and the founding Mills family retained a significant share of the company's stock after the IPO. Here is what investors need to know about Medline.

Loading paragraph...

IPO

IPO (Initial Public Offering) is the first sale of stock by a private company to the public, making it a publicly traded entity.

Loading definition...

How to buy Medline stock

If you want to buy shares of Medline, here are the steps you need to follow to add any stock to your personal investment portfolio.

Open your brokerage account: Log in to your brokerage account where you manage your investments. If you don't have one yet, take a look at our favorite brokers and trading platforms to find the right one.
Search for Medline: Enter the ticker MDLN in the search bar to open the stock's trading page.
Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
Submit your order: Confirm the details and submit your buy order.
Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.

Loading paragraph...

Should I invest in Medline?

Medline acts as a primary vendor for major medical networks, building long-term customer loyalty through a balanced mix of third-party distribution and its own proprietary brand catalog. Roughly half of its business comes from Medline-branded products, supported by a massive global footprint of international manufacturing plants and specialized kit assembly facilities. Its dedicated supply chain solutions division provides hospitals and nursing homes with advanced inventory management and data analytics to keep operations running smoothly.

By controlling both the production and distribution of its goods, Medline insulates itself from market volatility and uses a vast global network of regional warehouses. The company even bypasses traditional shipping bottlenecks by running its own private trucking fleet, MedTrans, which ensures reliable next-day delivery to most domestic customers. To lock in these relationships, Medline goes beyond physical supplies by embedding clinical training, continuing education, and digital care solutions directly into support for frontline medical teams.

In 2025, Medline's net sales rose 11.5% year over year to $28.4 billion, fueled by robust demand and significant new customer contracts. The company also generated $1.7 billion in net operating cash flow and $1.3 billion in free cash flow during its milestone IPO year. Investors looking for a steady business with a dominant footprint in the healthcare space may want to take a second look at Medline. However, investors seeking a high-growth stock might want to look elsewhere.

Loading paragraph...

NASDAQ: MDLN

Medline

Today's Change

(1.46%) $0.52

Current Price

$36.26

Key Data Points

Market Cap

$32B

Day's Range

$35.41 - $36.38

52wk Range

$29.00 - $50.88

Volume

5.3M

Avg Vol

7.6M

Gross Margin

23.85%

Loading company_card...

Is Medline profitable?

Yes, Medline is profitable. After a small net loss of $25 million in 2022, Medline swung to profitability, earning $234 million in 2023, $1.2 billion in 2024, and $1.2 billion in net income in 2025.

The company intends to use a significant portion of the IPO proceeds to pay down debt accumulated from its 2021 buyout, which is expected to improve its financial margins and free up cash flow in the years ahead.

Does Medline pay a dividend?

Medline does not currently pay a dividend. Given that it is newly public, Medline is unlikely to do so anytime soon.

How to invest in Medline through ETFs

Since Medline completed its IPO very recently, its stock may not yet be widely held by many ETFs. Some ETFs that hold shares of Medline include:

First Trust U.S. Equity Opportunities ETF (FPX +1.06%)
Renaissance IPO ETF (IPO +1.01%)
SPDR S&P Health Care Equipment ETF (XHE +1.48%)
Vanguard Health Care ETF (NASDAQ:VHCIX)
First Trust AlphaDEX Health Care ETF (FXH +1.37%)

Will Medline stock split?

Since Medline just went public, it is highly unlikely the company will execute a stock split anytime soon.

The bottom line

Investing in Medline is an opportunity to capitalize on the success of a highly resilient company that has quietly dominated healthcare logistics for decades. This is a reliable, cash-generating business primed to benefit from an aging population.

While factors like trade tariffs might cause some short-term bumps in margins and stock price, the company’s aggressive push to clear its debt leaves it in a strong position for steady, long-term growth.

Loading paragraph...

Investing in Medline FAQ

Loading faq...

About the Author

Rachel Warren is a contributing Motley Fool stock market analyst covering pharmaceuticals, biotechnology, medical devices, information technology, and consumer goods. Prior to The Motley Fool, Rachel was a paralegal and legal administrator. She holds a bachelor’s degree in paralegal studies from Liberty University School of Law.

TMFRachelW

Rachel Warren has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends S&P Global and Thermo Fisher Scientific. The Motley Fool recommends McKesson. The Motley Fool has a disclosure policy.

How to Buy Medline Stock (MDLN) in 2026

Key Points

IPO

How to buy Medline stock

Should I invest in Medline?

NASDAQ: MDLN

Key Data Points

Is Medline profitable?

Does Medline pay a dividend?

How to invest in Medline through ETFs

Will Medline stock split?

The bottom line

Related investing topics

Best IPO Stocks to Buy in 2026: Latest Upcoming Stocks to Watch

The Largest Healthcare Companies by Market Cap in October 2026

These Are Billionaires’ Favorite Healthcare Stocks

6 Best Health Insurance Stocks for 2026 and How to Invest

Investing in Medline FAQ

Can you buy stock in Medline?

Can you buy stock in Medline?

Is Medline publicly traded?

Is Medline publicly traded?

Is Medline going public?

Is Medline going public?

Is Medline a good stock to buy?

Is Medline a good stock to buy?

What is the future price of Medline stock?

What is the future price of Medline stock?

About the Author

Read Next

Stocks Mentioned

Motley Fool Stock Advisor’s Latest Pick

Premium Investing Services

IPO

How to buy Medline stock

Should I invest in Medline?

Best IPO Stocks to Buy in 2026: Latest Upcoming Stocks to Watch

The Largest Healthcare Companies by Market Cap in October 2026

These Are Billionaires’ Favorite Healthcare Stocks

6 Best Health Insurance Stocks for 2026 and How to Invest

Investing in Medline FAQ

Can you buy stock in Medline?

Can you buy stock in Medline?

Is Medline publicly traded?

Is Medline publicly traded?

Is Medline going public?

Is Medline going public?

Is Medline a good stock to buy?

Is Medline a good stock to buy?

What is the future price of Medline stock?

What is the future price of Medline stock?

Is Medline profitable?

Does Medline pay a dividend?

How to invest in Medline through ETFs

Will Medline stock split?

The bottom line

NASDAQ: MDLN

Key Data Points